Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
10/2005
10/05/2005CN1678569A Photostable cationic organic sunscreen compounds and compositions obtained therefrom
10/05/2005CN1678568A Standard compound for immunoassay for dioxin and method of immunoassay for dioxin
10/05/2005CN1676511A Terpinene-4-ol derivative and its use
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951884 Fluorobenzamides and uses thereof
09/2005
09/29/2005WO2005090286A1 Opioid receptor antagonists
09/29/2005WO2005090284A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
09/29/2005WO2005089354A2 Apparatus and method for applying variable localized pressure to the human body
09/29/2005WO2005089269A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005US20050215761 Aromatic glycols and polyols, preparation process and their use as monomers
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215435 Phenylalanine derivatives as herbicides
09/29/2005CA2558568A1 Opioid receptor antagonists
09/28/2005EP1579032A2 Hydrophobic-hydrophilic compounds for treating metallic surfaces
09/28/2005EP1578359A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
09/28/2005EP1474381B1 Phenylalanine derivatives as herbicides
09/28/2005CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087711A1 Method for the production of acetamide acetals
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087709A1 4-t-butylgabapentin and its synthesis
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005US20050209333 Malonamic acids and derivatives thereof as thyroid receptor ligands
09/22/2005US20050209327 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines
09/22/2005US20050209320 Compounds comprise an androgen receptor (AR) binding moiety which selectively targets the compounds to AR-expressing cancer cells, and a cytotoxic alkylating moiety, such as a nitrogen mustard moiety; (2R)-2-hydroxy-3-[(4-hydroxyphenyl)thio]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
09/22/2005US20050208084 Use of alkylamidomandelates as flavourings
09/22/2005DE102004010893A1 Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New ß-keto amide compounds with MCH-antagonistic effect and pharmaceutical compositions containing them
09/22/2005CA2570255A1 4-t-butylgabapentin and its synthesis
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577290A1 Amide compound and method of controlling plant disease with the same
09/21/2005EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1219832C Low foaming N, N'-dialkyl malic imine wetting agent
09/20/2005US6946575 for DNA analysis via fluorescent in situ hybridization (FISH)
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946453 Such as 7-azido-6-demethyl-6-deoxy-4-dedimethylamino tetracycline; for treatment of arthritis, bone disorders (osteoporosis), and emphysema
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2097676C 2,2-dimethyl 3[(z)1-propenyl] cyclopropane carboxylic acid and intermediates, and process for its preparation
09/15/2005WO2005085221A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/15/2005WO2005085182A1 Dl-hydroxybenzenamides having anticonvulsive activity
09/15/2005WO2005085181A1 Functional material comprising fluorine compound
09/15/2005WO2005068414A8 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifiying and obtaining the polymorphs thereof
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005US20050202974 Ketol fatty acid derivatives and plant growth regulators
09/15/2005CA2552907A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/14/2005EP1574495A1 Adamantane derivatives
09/14/2005EP1574494A1 Adamantane derivative
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005EP1572628A1 Isophtalic acid derivatives
09/14/2005EP1572627A1 Drugs for chronic pain
09/14/2005EP1572626A1 Therapeutic agents
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/13/2005US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
09/13/2005CA2058553C Preparation of e-oxime ethers of phenylglyoxylic esters
09/09/2005WO2005082860A1 Tetracyclines and their use as calpain inhibitors
09/08/2005US20050197511 Reacting an acid and an amine; apoptosis; carbamate, and N-phenethyl-2-phenylacetamide
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/08/2005US20050197302 Organic amine salt of closantel; administered with carrier and optionally macrocyclic lactone; bioavailability, blood concentration; veterinary medicine
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1492767B1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665774A Cinnamide derivatives
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005080316A2 Modulators of cannabinoid receptors
09/01/2005WO2005079541A2 Terephthalamide peptidomimetic compounds and methods
09/01/2005WO2005068403A3 Method for selective reduction of aromatic compounds
09/01/2005WO2005063665B1 Propofol analogs, process for their preparation, and methods of use
09/01/2005WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
09/01/2005US20050192359 For treating plant diseases; e.g. N-(3',4'-dimethoxy-6-methylbiphenyl-2-yl)-2-(2-propynyloxy)-2-(4-methylphenyl)acetamide
09/01/2005CA2556940A1 Modulator
09/01/2005CA2556447A1 Terephthalamide peptidomimetic compounds and methods
09/01/2005CA2555970A1 Therapeutic amide derivatives
08/2005
08/31/2005EP1567480A1 N-alkynyl-2-(substituted phenoxy) alkylamides and their use as fungicides
08/31/2005EP1567479A1 Fungicides
08/31/2005EP1567478A1 Method of producing nitrile compounds from ethylenically-unsaturated compounds
08/31/2005EP1567006A1 Fungicides
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1660782A Method for preparing 2-{4-[[(3, 5-dimethyl aniline) carbonyl] methyl] phenoxy} 2-methyl sodium propionate
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/30/2005US6936736 Vision defects; Parkinson's disease; Alzheimer's disease
08/30/2005US6936735 For protecting hair, skin and substrates such as polymers, textiles, fabrics, leathers and paints; cosmetics
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 157